Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print AMN107 has potent activity in leukemia resistant to Gleevec

AMN107 has potent activity in leukemia resistant to Gleevec

December 12, 2005

The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center (meeting abstract #37).

At the 47th Annual Meeting of the American Society of Hematology (ASH), the investigators reported marked improvement in outcome in all three phases of chronic myeloid leukemia (CML) as well as benefit in treating a form of acute lymphocytic leukemia (ALL) that shares the same genetic abnormality as CML, the Philadelphia chromosome.




"This drug is very promising and appears at this point to offer an effective option for patients who do not achieve an optimal response to Gleevec therapy," says Hagop Kantarjian, M.D., professor and chair of the Department of Leukemia.

If additional studies continue to show such results, Kantarjian says, he believes AMN107, which is taken in pill form, "will either replace Gleevec as the standard of care in the future or will be used in combination with it."

Both CML and Philadelphia-positive ALL is caused by the swapping of genetic material in bone marrow stem cells between two chromosomes, which produces an abnormality called the Philadelphia chromosome. This new gene then produces a novel tyrosine kinase (Bcr-Abl) that signals the abnormal cell growth that leads to development of leukemia.

While both Gleevec and AMN107 shut down the activity of Bcr-Abl, laboratory experiments with AMN107 show it is up to 50 times more potent because it binds more efficiently to the enzyme than does Gleevec.

In the phase I clinical trial being reported, 119 patients who were resistant to Gleevec were given AMN107, and in some cases the dose was increased up to twelve fold. The researchers found that the range of response varied, depending on the form of the cancer and the presence of genetic mutations. For example, hematologic response from the drug (defined as control of white blood cell counts) ranged from 44 percent to 100 percent in different subgroups of CML patients, and the more enduring cytogenetic response (elimination of cells with the cancer-causing defect) ranged from 22 percent to 100 percent. There was less overall response in ALL patients (ranging from 10 percent to 33 percent, depending on extent of disease).

Kantarjian notes that while some patients fared better than others with AMN107, these patients had little or no other treatment options available.

He says the results suggest that physicians soon will be able to tailor leukemia therapy according to the molecular profile of the disease, offering different treatments for subsets of patients based on their cancer's distinct molecular signature.

The collaborative study was led by M. D. Anderson and included the University of Frankfurt and Heidelberg University in Germany, the H. Lee Moffitt Cancer Center, Quest Diagnostics and Novartis Pharmaceuticals Corporation.

University of Texas M. D. Anderson Cancer Center



Related Leukemia Current Events and Leukemia News Articles Leukemia Current Events and Leukemia News RSS Leukemia Current Events and Leukemia News RSS
First use of antibody and stem cell transplantation to successfully treat advanced leukemia
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.

American Dietetic Association Releases Updated Position Paper Promoting and Supporting Breastfeeding
The American Dietetic Association has released an updated position paper on breastfeeding that details health benefits for both infants and mothers and encourages promotion of breastfeeding whenever possible.

Drug shows promise in treating dangerous complication of erectile disorder
Thousands of men are afflicted with an embarrassing and painful condition that triggers spontaneous, long-lasting erections. There are limited treatment options, but a solution could be on the way thanks to new research at The University of Texas Health Science Center at Houston.

Brain tumors in childhood leave a lasting mark on cognition, life status
Brain tumors in childhood cast a long shadow on survivors. The first study of the lasting impact of these tumors -- the most common solid malignancies in childhood -- shows that survivors have ongoing cognitive problems.

Researchers use drug-radiation combo to eradicate lung cancer
Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.

Propolis has proved to be a product with ability to have beneficial effects for health
Growing concerns about health has caused the scientific community to focus their interest on investigating functional foods which contribute to boosting the prevention and reduction of the risk of suffering from certain illnesses.

Chemosensitivity of cancer cells depends on their protein dependency
Two different anti-apoptotic proteins support cancer cell survival via an identical mechanism, yet differ in their sensitivity to chemotherapeutic drugs, report Brunelle et al. The study will be published online October 26, 2009 and in the November 2, 2009 print issue of the Journal of Cell Biology (JCB).

Drug could provide first treatment for scleroderma
Investigators have identified a drug that is currently approved to treat certain types of cancer, Gleevec, that could provide the first treatment for scleroderma, a chronic connective tissue disease for which a treatment has remained elusive.

New chromosomal abnormality identified in leukemia associated with Down syndrome
Researchers identified a new chromosomal abnormality in acute lymphoblastic leukemia (ALL) that appears to work in concert with another mutation to give rise to cancer. This latest anomaly is particularly common in children with Down syndrome.

Governor recognizes stem cell research at Einstein
Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today.
More Leukemia Current Events and Leukemia News Articles
100 Q&A About Leukemia, Second Edition (100 Questions & Answers about)

100 Q&A About Leukemia, Second Edition (100 Questions & Answers about)
by Edward D. Ball (Author)

This book deals with leukemia from a doctor's and a patient's perspective.

Childhood Leukemia: A Guide for Families, Friends and Caregivers (3rd Edition)

Childhood Leukemia: A Guide for Families, Friends and Caregivers (3rd Edition)
by Nancy Keene (Author)

This most complete parent guide available covers not only detailed and precise medical information about leukemia and the various treatment options, but also day-to-day practical advice on how to cope with procedures, hospitalization, family and friends, school, social and financial issues, communication, feelings, and, if therapy is not successful, the difficult issues of death and bereavement. Woven among the medical details and the practical advice are the voices of parents and children who have lived with leukemia and its treatments. As many parents have already found, advice from "veteran" parents can be a lifeline.This third edition contains significant updates to the information on treatments, chemotherapy drugs, bone marrow transplants, coping with side effects, and resources. It...

Living Through Leukemia: A Journey to Health

Living Through Leukemia: A Journey to Health
by Louis George Whitehead (Author)

While many believe that being diagnosed with leukemia is like being handed a death sentence, South Dakota native Louis George Whitehead provides living proof that survival of this life-threatening and life-changing illness is possible.

At age twenty-one, Whitehead’s doctor informs him that he is suffering from acute myeloid leukemia. After two rounds of chemotherapy and a relapse a few months later, Whitehead makes the decision to undergo a bone-marrow transplant. Living through Leukemia chronicles his story of endurance and optimism.

Whitehead shares his feelings following his initial diagnosis and through the realization that a fatal outcome was possible. He also details the events and symptoms leading up to his courageous battle and describes the importance of both his...

Fight Against Acute Lymphoblastic Leukemia Long Sleeve T-shirt Large White

Fight Against Acute Lymphoblastic Leukemia Long Sleeve T-shirt Large White
by Shop Zeus



Leukemia (The Biology of Cancer)

Leukemia (The Biology of Cancer)
by Donna M. Bozzone (Author)

This book includes full-color photographs, glossary, sidebars, further reading, web sites, references, and an index. Leukemia, or cancer of the blood or bone marrow, occurs in both acute and chronic forms. While the exact causes of the disease are not known, several risk factors have been identified. There are four major types of leukemia: acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphoid leukemia (ALL), and chronic lymphoid leukemia (CLL), and treatments include chemotherapy, radiation, and bone marrow transplants. "Leukemia" discusses the science of leukemia, theories about its causes, the history of the disease, and the current treatments and how they work.

Understanding MDS/Leukemia

Understanding MDS/Leukemia

Part of the award winning public television series Healthy Body/Healthy Mind. It can begin as a harmless case of fatigue but can lead to a blood transfusion or possible bone marrow transplant. It's a disease virtually unknown to the general public and often not diagnosed by medical caregivers. Mylodysplastic syndrome, or MDS, is a disorder of the bone marrow and can lead to leukemia and eventually death. In this program, success stories abound as researchers struggle to find answers.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

Adult Leukemia: A Comprehensive Guide for Patients and Families

Adult Leukemia: A Comprehensive Guide for Patients and Families
by Barbara Lackritz (Author)

For the tens of thousands of Americans with adult leukemia, the condition, which is really a group of diseases, is often a baffling one for patients and families to understand, and finding targeted information on individual conditions can be difficult. In straightforward language, Adult Leukemia: A Comprehensive Guide for Patients and Families addresses: Diagnosis and medical testsFinding a good oncologistTreatmentsSide effectsEmotional responses to diagnosis, treatment, remission, possible recurrenceGetting support from your family, friends, employers, and the broader community Author Barb "Grannybarb" Lackritz is a leading patient activist in the leukemia community and herself a long-term leukemia survivor. She emphasizes the promising emerging treatments for leukemia, covering in...

Leukemia Awareness Green Genuine Swarovski Crystal Bracelet

Leukemia Awareness Green Genuine Swarovski Crystal Bracelet
by SilverSpeck.com

This Beautiful Green Genuine Swarovski Crystal Bracelet Is the Perfect Bracelet you have been waiting for. It has a Sparking Glimmer and is beaded on a Comfort Stretch band. Looks great when worn with a few at a time or alone. Crystal beads can also be used to create your own jewelry! Very Stylish and Pretty!

When Cancer Calls … Say Yes to Life: The Story of One Man’s Journey through Leukemia

When Cancer Calls … Say Yes to Life: The Story of One Man’s Journey through Leukemia
by Rusty Hammer (Author)

“Rusty Hammer is an inspiration … We have watched his battle with admiration, for it is a tribute to the human spirit, and to the dignity and courage of a good man.”

—Mayor Antonio Villaraigosa, City of Los Angeles

Shortly after his fiftieth birthday in 2003, Rusty HammerÂ’s life irrevocably changed. Diagnosed with a rare and aggressive form of leukemia, he had two choices: fight or give in. And he chose to fight.

When Cancer Calls Â… Say Yes to Life shares Rusty HammerÂ’s courageous journey through cancer. With rare candor, Hammer describes how he faced his future with hope instead of succumbing to the blackness of despair. Hammer illustrates how imperative it is to live our lives to the fullest for our own emotional and physical well-being.

...

Fight Against Chronic Myelogenous Leukemia T-shirt Large White

Fight Against Chronic Myelogenous Leukemia T-shirt Large White
by Shop Zeus



© 2009 BrightSurf.com